KIES PETER 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
KIES PETER
CFO
Transactions
- Award
Common Stock Option
[F1]2026-03-04+31,240→ 31,240 totalExercise: $1.73Exp: 2036-02-26→ Common Stock (31,240 underlying) - Award
Restricted Stock Unit
[F2]2026-03-04+25,520→ 25,520 total→ Common Stock (25,520 underlying)
Footnotes (2)
- [F1]The vesting schedule for the 31,240 options granted on March 4, 2026 was as follows: 10,414 shares will vest on February 26, 2027; 10,413 shares will vest on February 26, 2028; 10,413 shares will vest on February 26, 2029.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Signature
/s/ Peter Kies|2026-03-05